TITLE

Levosimendan: a decade of experience in Europe built on years of evidence

AUTHOR(S)
Parissis, John; Toller, Wolfgang; Franco, Fatima; Delgado, Juan F.; Danou, Fotini; Llorens-Soriano, Pere; Karpati, Peter C.J.; Nieminen, Markku S.; Mebazaa, Alexandre; Follath, Ferenc
PUB. DATE
June 2008
SOURCE
European Journal of Heart Failure. Supplements;Jun2008, Vol. 7 Issue 2, p234
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Abstract: Recent European Society of Cardiology''s (ESC) guidelines on the diagnosis and treatment of acute heart failure (AHF), suggest that an essential target in the management of these patients is to improve symptoms within hours, which should persist until hospital release, also protecting renal function and avoiding ongoing myocardial injury. The vast experience built on the basis of evidence, accumulated regarding the use of levosimendan over the last 10 years, brings with it the possibility of utilizing this drug in multitude of new clinical scenarios. Newly discovered biologic effects of the drug on the failing heart, based on its anti-inflammatory, anti-apoptotic and anti-oxidative properties may explain the clinical efficacy of levosimendan in special sub-populations of AHF patients. This paper summarizes the current knowledge regarding the use of levosimendan in the early phase of the treatment of AHF, in acute coronary syndromes, its daily use in the critical care environment, perioperatively, and in patients with renal failure.
ACCESSION #
36114014

 

Related Articles

  • Ethnic differences in patient perceptions of heart failure and treatment: the West Birmingham heart failure project. Lip, G. Y. H.; Khan, H.; Bhatnagar, A.; Brahmabhatt, N.; Crook, P.; Davies, M. K. // Heart;Sep2004, Vol. 90 Issue 9, p1016 

    Objective: To investigate further the hypothesis that ethnic groups would have different levels of knowledge and perceptions of congestive heart failure (CHF) and treatments for this condition, a cross sectional survey was conducted of patients who were attending the heart failure clinics in two...

  • Mayo Clinic Researchers Discover Gene Mutations That 'Ignore' Stress, Lead to Heart Failure.  // Ascribe Newswire: Medicine;4/6/2004, p28 

    Mayo Clinic researchers have discovered genetic mutations in heart patients that make them vulnerable to heart failure because they produce an abnormal protein that can't decode stress messages from the body. Research team leader Andre Terzic, a specialist in cardiac biology, describes the work...

  • Randomised trial of telephone intervention in chronic heart failure: DIAL trial. Grancelli, H. // BMJ: British Medical Journal (International Edition);8/20/2005, Vol. 331 Issue 7514, p425 

    Objective: To determine whether a centralised telephone intervention reduces the incidence of death or admission for worsening heart failure in outpatients with chronic heart failure. Design: Multicentre randomised controlled trial. Setting: 51 centres in Argentina (public and private hospitals...

  • Effects of spironolactone on endothelial function converting enzyme activity, prognostic markers in patients with mild already taking optimal treatment function, vascular and other heart failure. Macdonald, J. E.; Kennedy, N.; A. D. Struthers // Heart;Jul2004, Vol. 90 Issue 7, p765 

    Objectives: To examine whether the favourable effects on endothelial function, vascular angiotensin converting enzyme (ACE) activity, cardiac remodelling, autonomic function, and QT intervals of spironolactone in combination with ACE inhibitor also occur in patients with New York Heart...

  • β blocker treatment is associated with improvement in renal function and anaemia in patients with heart failure. Khan, W.; Deepak, S. M.; Coppinger, T.; Waywell, C.; Borg, A.; Harper, L.; Williams, S. G.; Brooks, N. H. // Heart;Dec2006, Vol. 92 Issue 12, p1856 

    The article provides information on the effect of βblocker treatment associated with improvement in renal function and anemia in patients with heart failure. It has been explained that chronic renal impairment and anemia are common comorbidities associated with congestive heart failure. This...

  • Help for Failing Hearts.  // Medical Update;2005, Vol. 30 Issue 10, p5 

    Focuses on the results of a medical study which evaluated the efficiency of external counterpulsation therapy in preventing and treating heart diseases in U.S. patients in April 2005. Advantages of the treatment over drug therapy; Assessment of the effect of the therapy on patients with...

  • Use, tolerability and compliance of spironolactone in the treatment of heart failure. Lachaine, Jean; Beauchemin, Catherine; Ramos, Elodie // BMC Clinical Pharmacology;2011, Vol. 11 Issue 1, p4 

    Background: Risk of morbidity and mortality in patients with severe heart failure (HF) is reduced by blockade of aldosterone receptors with spironolactone. However, benefits of spironolactone are potentially limited by treatment compliance and adverse events profile. The aim of this study was to...

  • Levosimendan in the treatment of AHF: lessons from surveys and clinical trials. Mebazaa, Alexandre; Delgado, Juan F.; Franco, Fatima; Toller, Wolfgang; Parissis, John; Pini, Daniela; Giannakoulas, George; Gorjup, Vojka; Karpati, Peter C.J.; Follath, Ferenc; Nieminen, Markku S. // European Journal of Heart Failure. Supplements;Jun2008, Vol. 7 Issue 2, p228 

    Abstract: Acute heart failure (AHF) is a primary cause of hospital admission throughout the world. Several acute heart failure registries have been conducted in the United States (U.S.) and Europe assessing the clinical presentation of AHF in the real world. Of the five large registries two were...

  • Electrophysiologic Properties of Furosemide in Man. Gould, Lawrence; Chokshi, A.B.; Patel, S.; Gomes, G.I. // Angiology;Jan1983, Vol. 34 Issue 1, p53 

    Furosemide has been extensively used in the treatment of heart failure and its effect on cardiovascular dynamics are well established. Clinical relief of the symptoms of pulmonary congestion frequently precedes any demonstrable diuretic effect, suggesting that extra renal factors may also be...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics